Evidence map›Paper›PMID 29787037›Full record

ArticleEnvironmental health perspectives2018

Effects of Perinatal Exposure to Dibutyltin Chloride on Fat and Glucose Metabolism in Mice, and Molecular Mechanisms,

Raquel Chamorro-García, Bassem M Shoucri, Sigal Willner, Heidi Käch, Amanda Janesick, Bruce Blumberg

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Environmental Obesogens and Their Perturbations in Lipid Metabolism.Environment & health (Washington, D.C.) · 2024
    Review
  8. Article
  9. Obesogens: a unifying theory for the global rise in obesity.International journal of obesity (2005) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Aging and obesity prime the methylome and transcriptome of adipose stem cells for disease and dysfunction.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Obesity and endocrine-disrupting chemicals.Endocrine connections · 2021
    Review
  19. The new kids on the block: Emerging obesogens.Advances in pharmacology (San Diego, Calif.) · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raquel Chamorro-GarcíaDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Bassem M ShoucriDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Sigal WillnerDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Heidi KächDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Amanda JanesickDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Bruce BlumbergDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
University of California, Irvine · US

Funding

Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphismR01ES023316 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BRUCE BLUMBERG, TOSHIHIRO SHIODA · 2013 to 2026
$8.3M
Endocrine disruption by organotins in obesity and diabetesR01ES015849 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE · 2007 to 2011
$2.2M
Endocrine disrupter modulation of SXR in development and lymphomagenesisR01ES021832 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE · 2013 to 2017
$1.9M
NIEHS NIH HHS R01 ES015849NIEHS NIH HHS R01 ES021832NIEHS NIH HHS R01 ES023316
6 · The paper itself

Abstract

backgroundThe organotin dibutyltin (DBT) is used in the manufacture of polyvinyl chloride (PVC) plastics, in construction materials, and in medical devices. Previous animal studies showed detrimental effects of DBT during

objectivesWe tested the potential obesogenic effects of DBT using

methodsWe evaluated the effects of DBT on nuclear receptor activation and adipogenic potential using human and mouse multipotent mesenchymal stromal stem cells (MSCs). We also evaluated the effects of perinatal exposure to environmentally relevant doses of DBT in C57BL/6J mice.

resultsDBT activated human and mouse PPARγ and RXRα in transient transfection assays, increased expression of adipogenic genes, promoted adipogenic differentiation and increased lipid accumulation in mouse and human MSCs,

conclusionsDBT acted as an obesogen by inducing lipid accumulation in human and mouse MSCs through a PPARγ-dependent pathway.

Indexed as

AdipogenesisAnimalsCell DifferentiationCells, CulturedCell SurvivalFemaleGlucoseHumansLipid MetabolismMaleMiceMice, Inbred C57BLOrganotin CompoundsPPAR gammaRetinoid X ReceptorsSignal Transductiondi-n-butyltinGlucoseOrganotin CompoundsPPAR gammaRetinoid X Receptors

Identifiers

PMID29787037
PMCPMC6072003
OpenAlexW2804762199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.